Skip to main content
logo
Duality Biotherapeutics, Inc. (HKG:9606)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
201.80
+0.20 (0.10%)
Sep 30, 2026, 4:08 PM HKT

Duality Biotherapeutics Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23
Net Income
-1,439-2,595-1,050-357.51
Depreciation & Amortization
13.8512.327.874.76
Other Amortization
---0.23
Asset Writedown & Restructuring Costs
--21.35-
Loss (Gain) From Sale of Investments
---1.16
Stock-Based Compensation
108.81156.05190.4123.96
Other Operating Activities
31.332,311855.93903.91
Change in Accounts Receivable
46.5569.39-276.77-120.97
Change in Accounts Payable
243.7586.52463.06154.46
Change in Unearned Revenue
54.83-12.22112.21216.3
Change in Other Net Operating Assets
120.5166.5-37.86-9.95
Operating Cash Flow
-818.88194.58285.78816.34
Operating Cash Flow Growth
--31.91%-64.99%-

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23
Capital Expenditures
-14.34-11.5-4.08-11.28
Sale (Purchase) of Intangibles
-2.36-2.22-27.1-24.62
Investment in Securities
-53.58-1,894-177.46-
Other Investing Activities
-22.17-4.55-2.51-42.65
Investing Cash Flow
-92.45-1,913-211.15-78.55

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23
Short-Term Debt Issued
-141.06--
Total Debt Issued
309.08141.06--
Long-Term Debt Repaid
--4.43-3.4-3.5
Lease Payments
-4.55-4.43-3.4-3.5
Net Debt Issued (Repaid)
304.53136.62-3.4-3.5
Issuance of Common Stock
14.011,757--
Other Financing Activities
-4.69-84.65-4.22-1.59
Financing Cash Flow
245.721,809-7.6210.82

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23
Foreign Exchange Rate Adjustments
-63.08-23.3311.016.31
Net Cash Flow
-728.6967.4978.02754.92

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23
Free Cash Flow
-833.23183.08281.7805.05
Free Cash Flow Growth
--35.01%-65.01%-
Free Cash Flow Margin
-98.94%9.89%14.51%45.06%
Free Cash Flow Per Share
-9.322.8135.21100.63
Levered Free Cash Flow
-170.52-3,0371,045-
Unlevered Free Cash Flow
-168.53-3,0371,045-
Free Cash Flow After Leases
-837.77178.65278.31801.55

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23
Cash Interest Paid
2.981.210.250.19
Cash Income Tax Paid
--90.0554.54248.93
Change in Working Capital
465.63310.19260.65239.83